U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07650643) titled 'EEG Biomarkers for ADHD Stimulant Treatment' on June 09.
Brief Summary: Pediatric attention deficit hyperactivity disorder (ADHD) affects up to 10% of children in the U.S. and more than 90% are prescribed stimulant medications according to clinical guidelines. The standard of care for pharmacological treatment of ADHD is a "trial-and-error" approach that requires frequent dose adjustments, side effects management, and communication among doctors, parents, and school personnel over weeks, months, and years. In the first year following prescription of stimulant medications, >50% of doctors are not able to conduct the recommended follo...